Biotricity announces the launch of its direct-to-consumer heart health screening program, HeartSecure. Someone in the world dies of cardiovascular disease every 1.5 seconds. In the U.S. alone, 127 million adults have at least 1 risk factor for heart disease, and 1 out of every 3 deaths is attributed to heart disease. To encourage preventative heart care and help reduce the prevalence of CVD, Biotricty is providing a limited-time discounted launch offer for HeartSecure. Early detection of heart disease and prompt intervention can slash the risk of heart attack and stroke by over 80%. A shortage in resources and cardiac professionals, an increasing chronically ill aging population, and limitations of insurance carriers, have led to an average wait time of about 1 month for a heart health screening with a cardiologist. HeartSecure reduces these barriers to provide a seamless and affordable solution for proactive cardiac health management. This innovative service is designed to meet the critical and escalating demand for accessible, timely cardiac health screening.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BTCY:
- Biotricity sees 2024 revenue growth exceeding 24% year-over-year
- Biotricity to launch direct-to-patient cardiac screening service HeartSecure
- Biotricity files to sell 1.42M shares of common stock for holders
- Biotricity files $50M mixed securities shelf
- Biotricity announces partnerships with home-based diagnostic companies
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue